Surgery as a Treatment for Medically Intractable Epilepsy | MicrobiomeTrials← Back to trialsNCT01273129
Surgery as a Treatment for Medically Intractable Epilepsy
RecruitingOBSERVATIONAL
Trial Details
Enrollment target: 300 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Drug Resistant Epilepsy
The purpose of this study is to assess the safety and performance of the iVEAcare Neuromodulation System for the treatme…
Multiple LocationsEst. completion Jun 2027
Rett Syndrome
Rett syndrome (RTT) is a rare genetic neurodevelopmental disorder caused primarily by mutations in the MECP2 gene, leadi…
Fortaleza, BrazilCompleted Jun 2027
Recruiting
ENDEAVOR is a Phase 1/2, 2-part, multicenter study to evaluate the safety and efficacy of ETX101 in participants with SC…
San Francisco, United StatesEst. completion Jan 2028